Bio-gen Extracts, a player in the natural ingredients industry, is thrilled to announce the receipt of a coveted Natural Product Number (NPN) from Health Canada for its innovative marigold extract, Lute-gen. This significant milestone underscores Bio-gen Extracts' commitment to scientific excellence, product quality, and consumer well-being.
Lute-gen is a meticulously crafted extract derived from marigold flowers (Tagetes erecta), rich in lutein and zeaxanthin. The NPN (#80126402) empowers consumers to make confident choices about their health by endorsing a range of visual and cognitive health benefits associated with Lute-gen.
Twelve distinct claims have been approved under the "Recommended use or purpose" category, reinforcing the product's efficacy and potential.
With Health Canada's issuance of the NPN, Lute-gen now stands validated for its safety, efficacy, and quality. The NPN process, conducted in accordance with the Natural Health Products Regulations, underscores Bio-gen Extracts' unwavering dedication to meeting rigorous health and safety standards. Consumers can trust that Lute-gen has undergone a comprehensive assessment by Health Canada, further enhancing its credibility in the market.
At the heart of Lute-gen lies a foundation of clinical research, technological innovation, and meticulous supply chain traceability. This multifaceted approach ensures that each aspect of the product's journey aligns with the highest industry standards. Bio-gen Extracts' continuous investment in advancing research propels Lute-gen to meet evolving regulatory and consumer demands. The NPN itself stands as a resounding testament to the robust data accumulated through extensive clinical studies on Lute-gen.
Bio-gen Extracts' growth trajectory in the carotenoids market is poised for acceleration with Lute-gen at the forefront. The company's dedication to research and development extends beyond Lute-gen to encompass their synergistic carotenoid complex, CaroRite.
